fat

Vivus Adds 12% in Early Trading on Qnexa Study Results

blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Watch for Continued Gains in Shares of W...

Weingarten Realty Investors (NYSE:WRI) traded today at a new 52-week high of $34.07. S ...

VCA Antech Looks to Continue to Trade Ab...

Shares of VCA Antech (NASDAQ:WOOF) traded at a new 52-week high today of $38.05. So fa ...

WellPoint: 52-Week High Recently Eclipse...

WellPoint (NYSE:WLP) traded at a new 52-week high today of $116.26. Approximately 1.5 ...

Shares of Whiting Petroleum Rise Above P...

Whiting Petroleum (NYSE:WLL) traded today at a new 52-week high of $88.90. This new hi ...

Windstream: The Winning Streak Continues...

Shares of Windstream (NASDAQ:WIN) traded today at $10.35, breaking its 52-week high. S ...

Shares of Vanguard Natural Resources Ris...

Shares of Vanguard Natural Resources (NYSE:VNR) traded at a new 52-week high today of $ ...

Watch for Continued Gains in Shares of U...

Union Pacific (NYSE:UNP) traded today at a new 52-week high of $102.98. So far today a ...

Take-Two Interactive Software: The Winni...

Shares of Take-Two Interactive Software (NASDAQ:TTWO) traded today at $23.48, breaking ...

Most Popular Video News